Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Market Capitalization	109	94	84	440	478	542
Market Cap Growth	28.37%	11.77%	-80.85%	-7.93%	-11.78%	500.40%
Enterprise Value	-6	-44	-8	291	391	478
Last Close Price	2.77	2.10	1.95	10.50	10.50	15.79
PE Ratio	2.91	-	16.87	-	-	-
PS Ratio	63.82	-	69.54	174.08	200.54	236.73
PB Ratio	0.63	0.67	0.57	3.11	3.26	5.49
P/TBV Ratio	0.63	0.67	0.57	3.10	3.27	5.53
EV/Sales Ratio	-	-	-	115.15	163.83	208.87
EV/FCF Ratio	0.62	-	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01
Net Debt / Equity Ratio	-0.66	-0.97	-0.69	-1.02	-0.90	-0.86
Net Debt / EBITDA Ratio	10.38	11.25	7.21	3.82	4.05	4.15
Net Debt / FCF Ratio	12.62	16.79	10.64	5.45	4.48	4.65
Asset Turnover	0.01	-	0.01	0.02	-	0.03
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%
Earnings Yield	34.36%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%
FCF Yield	-8.31%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.